摘要
目的观察国产药物洗脱支架治疗急性冠状动脉综合症(ACS)与单纯药物治疗疗效两者进行比较。方法选择124例住院ACS患者,其中42例接受支架治疗,82例选择单纯传统药物治疗,比较2组患者住院期间及随访6个月死亡数、心功能情况、心绞痛发作情况及再住院情况。结果2组患者入院时临床情况差异无统计学意义,住院期间及随访期间2组总心脏事件发生差异有统计学意义。结论国产雷帕霉素洗脱支架治疗ACS患者较传统单纯药物治疗更安全有效。
Objective To compare the efficacy of sirolimus-eluting stents (SES) made in China in patients with acute coronary syndrome with the efficacy of simplex medicine treatment. Methods 124 patients with ACS underwent different treatment:42 treated with SES made in China ( SES group) and 82 with medicine treatment ( Medicine group) . Compare the number of death , the instance of heart function , recurrence of angina and the number of going to hospital once again during being in the hospital and follow - up were recorded. Results The two groups of patients were almost the same , but were enormously different in heart circumstance ( the number of death were 1 : 8, the number of going to hospital were 6: 23, the improver of EF was 59.6 to 54.2, P = 0. 021 ). Conclusions The SES made in China is more effective and safer than simplex medicine treatment.
出处
《实用全科医学》
2007年第12期1066-1067,共2页
Applied Journal Of General Practice